Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S100A4 | P26447 | 7/20 | 0.84 |
| ▸ | PAX8 | Q06710 | 5/20 | 0.84 |
| ▸ | BRCA1 | P38398 | 7/20 | 0.81 |
| ▸ | STAT6 | P42226 | 5/20 | 0.81 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.81 |
| ▸ | P4HB | P07237 | 1/20 | 0.81 |
| ▸ | MEN1 | O00255 | 9/20 | 0.79 |
| ▸ | THRB | P10828 | 9/20 | 0.79 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.79 |
| ▸ | RECQL | P46063 | 8/20 | 0.79 |
| ▸ | BLM | P54132 | 8/20 | 0.79 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.79 |
| ▸ | HIF1A | Q16665 | 7/20 | 0.79 |
| ▸ | MAPT | P10636 | 7/20 | 0.79 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.79 |
| ▸ | MAPK1 | P28482 | 6/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.79 |
| ▸ | USP2 | O75604 | 5/20 | 0.79 |
| ▸ | TOP2A | P11388 | 5/20 | 0.79 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Zorubicin SCHEMBL13840951 | 1.00 | S100A4 (0.84) | S100A4PAX8BRCA1STAT6CYP1A2 | |
| Zorubicin SCHEMBL1651187 | 1.00 | S100A4 (0.84) | S100A4PAX8BRCA1STAT6CYP1A2 | |
| Zorubicin SCHEMBL29352324 | 1.00 | S100A4 (0.84) | S100A4PAX8BRCA1STAT6CYP1A2 | |
| Zorubicin SCHEMBL8232 | 1.00 | S100A4 (0.84) | S100A4PAX8BRCA1STAT6CYP1A2 | |
| Zorubicin SCHEMBL4023 | 0.99 | S100A4 (0.83) | S100A4PAX8BRCA1STAT6CYP1A2 | |
| Zorubicin SCHEMBL29617182 | 0.99 | S100A4 (0.83) | S100A4PAX8BRCA1STAT6CYP1A2 | |
| Zorubicin SCHEMBL4024 | 0.99 | S100A4 (0.83) | S100A4PAX8BRCA1STAT6CYP1A2 | |
| Zorubicin SCHEMBL27835878 | 0.98 | S100A4 (0.81) | S100A4PAX8BRCA1STAT6CYP1A2 | |
| Zorubicin SCHEMBL28142133 | 0.98 | MEN1 (0.82) | S100A4PAX8BRCA1STAT6CYP1A2 | |
| Zorubicin SCHEMBL4759324 | 0.96 | MEN1 (0.79) | S100A4PAX8BRCA1STAT6CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 47259 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4748859-A2 | CHEMICALLY AND PHOTOCHEMICALLY INITIATED CELL MEMBRANE BLEBBING TO INDUCE CELL VESICLE PRODUCTION, MODIFICATIONS THEREOF, AND USES THEREOF | The Regents of the University of California (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260137794-A1 | LIGAND-DRUG CONJUGATE AND USE THEREOF | SYSTIMMUNE INC (US) | 2026-05-21 | — | — | US | claimed |
| EP-4743490-A1 | HUMANIZED ANTI-CD7 ANTIBODY | Christian-Albrechts-Universität zu Kiel (DE) | 2026-05-20 | — | — | EP | claimed |
| WO-2026099502-A1 | NOVEL DRUG CONJUGATES FOR TESTING CELLULAR DRUG UPTAKE | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2026-05-15 | — | — | WO | claimed |
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-20260115305-A1 | LINKERS, CONJUGATES AND APPLICATIONS THEREOF | GENEQUANTUM HEALTHCARE SUZHOU CO LTD (CN) | 2026-04-30 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| EP-4727589-A1 | PROTAMINE-COATED NUCLEIC ACID/THERAPEUTIC AGENT COMPLEXES, AND USES THEREOF | The Regents of the University of California (US) | 2026-04-22 | — | — | EP | claimed |
| US-20260091119-A1 | ISOLATED TARGETED DELIVERY SYSTEM FOR THE TREATMENT OF GLIOMA | CELLIS AG (CH) | 2026-04-02 | — | — | US | claimed |
| US-20260085061-A1 | PHTHALAZINE DERIVATIVES AS PYRUVATE KINASE MODULATORS | SITRYX THERAPEUTICS LIMITED (GB) | 2026-03-26 | — | — | US | claimed |
| US-5043166-A | Antitumor agents; side effect reduction | HADASIT MEDICAL RESEARCH, INC. (IL) | 1991-08-27 | — | — | US | claimed |
| CN-1053238-A | Morpholinyl derivatives of doxorubicin and process for their preparation | FARMTALIA CARLO ERBA S R L (IT) | 1991-07-24 | — | — | CN | claimed |
| EP-0401243-A1 | MEDICINAL PREPARATIONS CHARACTERIZED BY A COMBINATION OF CYTOSTATIC AGENTS, HORMONAL THERAPEUTIC AGENTS AND PHOSPHONE DERIVATIVES. | HENKEL KGAA (DE) | 1990-12-12 | — | — | EP | claimed |
| EP-0393575-A1 | Neoplasia treatment compositions containing antineoplastic agent and side-effect reducing protective agent | G.D. Searle & Co. (US) | 1990-10-24 | — | — | EP | claimed |
| CN-1040985-A | Anthracycline derivatives and their manufacture method | SANRAKU INC (JP) | 1990-04-04 | — | — | CN | claimed |
| CN-1037904-A | 3 '-deaminizating-4 '-deoxidation-4 '-the amino anthracene cyclic cpds | ERBA FARMITALIA (IT) | 1989-12-13 | — | — | CN | claimed |
| CN-1037539-A | The manufacture method of new antitumor antibiotic C-1027 | INST OF BIOLOG TECHNOLOGY OF M (CN) | 1989-11-29 | — | — | CN | claimed |
| WO-1989007453-A1 | MEDICINAL PREPARATIONS CHARACTERIZED BY A COMBINATION OF CYTOSTATIC AGENTS, HORMONAL THERAPEUTIC AGENTS AND PHOSPHONE DERIVATIVES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1989-08-24 | — | — | WO | claimed |
| US-4331648-A | CARDIOTONIC AGENTS; MOUTH | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1982-05-25 | — | — | US | claimed |
| US-4320110-A | Carnitine and its use in reducing cardiac toxicity and as a synergist with cytostats | FELICE STEPHEN L DE | 1982-03-16 | — | — | US | claimed |